Drug Type Chemical drugs |
Synonyms 제뉴원씨코바액 |
Target- |
Action- |
Mechanism Vitamin C supplements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (16 Oct 2024), |
Regulation- |
Molecular FormulaC72H100CoN18O17P |
InChIKeyDWKMERNBNCCNEZ-RQKYJTTQSA-M |
CAS Registry13870-90-1 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Epistaxis | South Korea | 16 Oct 2024 | |
Gingival Hemorrhage | South Korea | 16 Oct 2024 | |
Skin Pigmentation | South Korea | 16 Oct 2024 |